AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Allogene Therapeutics (ALLO) stock Forecast for 2023, 2024, 2025, 2026
The forecast has been updated: December 3, 2023 12:52
Allogene Therapeutics stock price online today
Analyst Target Price
16.93Dividend Date
-Ex Dividend Date
-Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2023, 2024, 2025?
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $16.93 target price for Allogene Therapeutics stock stock.
Today 200 Day Moving Average is the resistance level (6.03 $).
50 Day Moving Average is the resistance level (4.648 $).
Allogene Therapeutics stock monthly Forecast
| Date | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| 05 Dec 23 | 5.05 | 4.94 | 5.17 | 4.65 % |
| 06 Dec 23 | 5.08 | 4.88 | 5.17 | 5.82 % |
| 07 Dec 23 | 5.19 | 4.99 | 5.28 | 5.83 % |
| 08 Dec 23 | 5.02 | 4.75 | 5.14 | 8.21 % |
| 09 Dec 23 | 5.16 | 5.04 | 5.34 | 5.88 % |
| 10 Dec 23 | 4.99 | 4.76 | 5.19 | 9.19 % |
| 11 Dec 23 | 4.82 | 4.66 | 4.94 | 5.86 % |
| 12 Dec 23 | 4.65 | 4.42 | 4.91 | 11.29 % |
| 13 Dec 23 | 4.38 | 4.30 | 4.55 | 5.77 % |
| 14 Dec 23 | 4.21 | 4.01 | 4.36 | 8.83 % |
| 15 Dec 23 | 3.95 | 3.89 | 4.04 | 3.91 % |
| 16 Dec 23 | 4.13 | 3.91 | 4.31 | 10.21 % |
| 17 Dec 23 | 4.28 | 4.11 | 4.42 | 7.43 % |
| 18 Dec 23 | 4.19 | 4.12 | 4.37 | 5.98 % |
| 19 Dec 23 | 4.31 | 4.09 | 4.44 | 8.56 % |
| 20 Dec 23 | 4.61 | 4.49 | 4.81 | 7.18 % |
| 21 Dec 23 | 4.83 | 4.75 | 5.10 | 7.48 % |
| 22 Dec 23 | 5.12 | 4.84 | 5.22 | 7.92 % |
| 23 Dec 23 | 4.89 | 4.82 | 4.99 | 3.41 % |
| 24 Dec 23 | 4.57 | 4.42 | 4.71 | 6.51 % |
| 25 Dec 23 | 4.48 | 4.37 | 4.64 | 6.26 % |
| 26 Dec 23 | 4.24 | 4.08 | 4.32 | 5.89 % |
| 27 Dec 23 | 4.40 | 4.28 | 4.62 | 7.83 % |
| 28 Dec 23 | 4.44 | 4.20 | 4.61 | 9.70 % |
| 29 Dec 23 | 4.33 | 4.15 | 4.45 | 7.23 % |
| 30 Dec 23 | 4.29 | 4.07 | 4.43 | 8.95 % |
| 31 Dec 23 | 4.25 | 4.12 | 4.46 | 8.23 % |
| 01 Jan 24 | 4.24 | 4.14 | 4.37 | 5.74 % |
| 02 Jan 24 | 4.19 | 4.13 | 4.33 | 4.90 % |
| 03 Jan 24 | 4.16 | 4.03 | 4.25 | 5.49 % |
ALLO daily forecast for this month
Estimated Average Forecasted Allogene Therapeutics Price: 5.05 Positive intraday dynamics of the instrument is expected with 4.441% volatility is expected.
Pessimistic forecast: 4.94
Optimistic: 5.17
Allogene Therapeutics stock forecast for 06.12.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 5.08 Positive intraday dynamics of the instrument is expected with 5.500% volatility is expected.
Pessimistic forecast: 4.88
Optimistic: 5.17
Allogene Therapeutics stock forecast for 07.12.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 5.19 Positive intraday dynamics of the instrument is expected with 5.508% volatility is expected.
Pessimistic forecast: 4.99
Optimistic: 5.28
Allogene Therapeutics stock forecast for 08.12.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 5.02 Negative intraday dynamics of the instrument is expected with 7.584% volatility is expected.
Pessimistic forecast: 4.75
Optimistic: 5.14
Allogene Therapeutics stock forecast for 09.12.2023.
Estimated Average Forecasted Allogene Therapeutics Price: 5.16 Positive intraday dynamics of the instrument is expected with 5.550% volatility is expected.
Pessimistic forecast: 5.04
Optimistic: 5.34
ALLO Forecast for 2023
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Dec | 4.87 | 4.64 | 5.06 | 8.28 % |
Allogene Therapeutics stock forecast for this year
Allogene Therapeutics share price average forecast for Dec 2023 is: 4.87072 The dynamics are negative.
Allogene Therapeutics stock Forecast for 2024
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 5.12 | 4.89 | 5.36 | 8.80 % |
| Feb | 4.94 | 4.72 | 5.24 | 9.81 % |
| Mar | 5.13 | 4.81 | 5.36 | 10.24 % |
| Apr | 5.27 | 4.89 | 5.63 | 13.28 % |
| May | 5.25 | 4.83 | 5.51 | 12.30 % |
| Jun | 5.52 | 5.32 | 5.91 | 9.90 % |
| Jul | 5.29 | 5.10 | 5.62 | 9.30 % |
| Aug | 5.10 | 4.92 | 5.21 | 5.58 % |
| Sep | 4.92 | 4.79 | 5.16 | 7.06 % |
| Oct | 4.93 | 4.75 | 5.03 | 5.59 % |
| Nov | 4.80 | 4.61 | 5.13 | 10.11 % |
| Dec | 5.01 | 4.75 | 5.27 | 9.80 % |
Allogene Therapeutics stock Forecast for 2025
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 5.46 | 5.04 | 5.72 | 11.94 % |
| Feb | 5.82 | 5.59 | 6.19 | 9.77 % |
| Mar | 6.13 | 5.73 | 6.59 | 13.12 % |
| Apr | 6.50 | 6.22 | 6.73 | 7.63 % |
| May | 6.24 | 5.90 | 6.55 | 10.00 % |
| Jun | 6.14 | 6.02 | 6.59 | 8.67 % |
| Jul | 6.26 | 5.83 | 6.76 | 13.70 % |
| Aug | 6.35 | 6.15 | 6.79 | 9.45 % |
| Sep | 6.46 | 6.21 | 6.81 | 8.73 % |
| Oct | 6.70 | 6.31 | 7.22 | 12.70 % |
| Nov | 6.79 | 6.36 | 7.08 | 10.16 % |
| Dec | 7.14 | 6.94 | 7.54 | 7.87 % |
Allogene Therapeutics stock Forecast for 2026
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 7.61 | 7.45 | 8.15 | 8.68 % |
| Feb | 8.29 | 7.88 | 8.53 | 7.68 % |
| Mar | 7.53 | 7.05 | 7.96 | 11.35 % |
| Apr | 7.31 | 7.01 | 7.67 | 8.58 % |
| May | 7.12 | 6.97 | 7.50 | 7.03 % |
| Jun | 6.95 | 6.56 | 7.37 | 11.03 % |
| Jul | 6.85 | 6.66 | 7.23 | 7.86 % |
| Aug | 7.14 | 6.59 | 7.52 | 12.35 % |
| Sep | 7.12 | 6.78 | 7.47 | 9.33 % |
| Oct | 7.33 | 7.08 | 7.58 | 6.67 % |
| Nov | 7.29 | 6.85 | 7.54 | 9.19 % |
| Dec | 7.67 | 7.13 | 7.99 | 10.75 % |
Allogene Therapeutics stock Forecast for 2027
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 7.74 | 7.30 | 8.29 | 11.87 % |
| Feb | 8.46 | 8.15 | 8.85 | 7.94 % |
| Mar | 7.70 | 7.29 | 7.94 | 8.15 % |
| Apr | 7.46 | 7.24 | 7.97 | 9.17 % |
| May | 7.66 | 7.31 | 8.09 | 9.56 % |
| Jun | 7.83 | 7.43 | 8.33 | 10.89 % |
| Jul | 7.82 | 7.29 | 8.38 | 12.97 % |
| Aug | 8.44 | 7.82 | 8.81 | 11.29 % |
| Sep | 9.03 | 8.85 | 9.67 | 8.41 % |
| Oct | 9.01 | 8.68 | 9.61 | 9.65 % |
| Nov | 8.69 | 8.04 | 8.92 | 9.84 % |
| Dec | 9.42 | 8.87 | 9.64 | 8.02 % |
Allogene Therapeutics overview
Allogene Therapeutics Address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, USMarket Capitalization
678 885 000 $EBITDA
-344 372 992PE Ratio
NonePEG Ratio
NoneDividend Per Share
0Dividend Yield
0EPS
-2.54Quarterly Earnings Growth YOY
0Quarterly Revenue Growth YOY
-0.488Trailing PE
-Forward PE
-EV To Revenue
2674.75EV To EBITDA
-2.22152 Week High
12.2152 Week Low
3.0850 Day Moving Average
4.648200 Day Moving Average
6.03Shares Outstanding
145842000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.